Ischemic preconditioning of the liver: A few perspectives from the bench to bedside translation

Liver Transplantation

Volumn 14, Issue 11, 2008, Pages 1569-1577

  Desai, Kunj K ^a   Dikdan, George S ^a   Shareef, Asif ^a   Koneru, Baburao ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BRAIN DEATH; CLINICAL EFFECTIVENESS; CRYOPRESERVATION; DISEASE SEVERITY; EXPERIMENTAL TRANSPLANTATION; FATTY LIVER; GRAFT SURVIVAL; HUMAN; ISCHEMIC PRECONDITIONING; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER ISCHEMIA; LIVER RESECTION; LIVER TRANSPLANTATION; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SURVIVAL RATE;

AGED; ANIMALS; BRAIN DEATH; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MIDDLE AGED; REPERFUSION INJURY; TIME FACTORS;

EID: 57849161025     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21630     Document Type: Review

References (85)

1. Peralta C, Closa D, Xaus C, Gelpí E, Roselló-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998;28: 768-773.
2. Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998;66:152-157.
3. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002;33:1889-1898.
4. Schmidt R, Tritschler E, Hoetzel A, Loop T, Humar M, Halverscheid L, et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann Surg 2007;245: 931-942.
5. Terajima H, Enders G, Thiaener A, Hammer C, Kondo T, Thiery J, et al. Impact of hyperthermic preconditioning on postischemic hepatic microcirculatory disturbances in an isolated perfusion model of the rat liver. Hepatology 2000; 31:407-415.
6. Nakayama H, Yamamoto Y, Kume M, Yamagami K, Yamamoto H, Kimoto S, et al. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999;126:945-954.
7. Donckier V, Loi P, Closset J, Nagy N, Quertinmont E, Le Moine O, et al. Preconditioning of donors with interleukin-10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs. Transplantation 2003; 75:902-904.
8. Zager RA, Baltes LA, Sharma HM, Jurkowitz MS. Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 1984;26:689-700.
9. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
10. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 2007;12:181-188.
11. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003;125:1480-1491.
12. Murphy E, Steenbergen C. Preconditioning: the mitochondrial connection. Annu Rev Physiol 2007;69:51-67.
13. Tsai BM, Wang M, March KL, Turrentine MW, Brown JW, Meldrum DR. Preconditioning: evolution of basic mechanisms to potential therapeutic strategies. Shock 2004;21: 195-209.
14. Serafin A, Fernandez-Zabalegui L, Prats N, Prats N, Wu ZY, Roselló-Catafau J, et al. Ischemic preconditioning: tolerance to hepatic ischemia-reperfusion injury. Histol Histopathol 2004;19:281-289.
15. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg 2003;20:383-396.
16. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006;244:921-928; discussion 928-930.
17. Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004;135:203-214.
18. Yellon DM, Hausenloy DJ. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med 2005;2:568-575.
19. Baron PW, Sindram D, Higdon D, Howell DN, Gottfried MR, Tuttle-Newhall JE, et al. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transpl 2000;6:407-412.
20. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238:843-850; discussion 851-852.
21. Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, et al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg 2005;140:129-136.
22. Amador M, Marti J, Rodriguez-Laiz G, Bombuy E, Alvarez G, Ferrer J, et al. Ischemic preconditioning during donor procurement in orthotopic liver transplantation. Preliminary results of a prospective and randomized trial. J Hepatol 2004;40:37.
23. Nuzzo G, Giuliante F, Vellone M, De Cosmo G, Ardito F, Murazio M, et al. Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 2004;10(2 suppl 1):S53-S537.
24. Koneru B, Fisher A, He Y, Skurnick J, Wilson DJ, de la Torre AN, et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 2005;11:196-202.
25. Azoulay D, Del Gaudio M, Andreani P, Ichai P, Sebag M, Adam R, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 2005;242: 133-139.
26. Jassem W, Fuggle SV, Cerundolo L, Heaton ND, Rela M. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006;81:169-174.
27. Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006;12:628-635.
28. Amador A, Grande L, Marti J, Deulofeu R, Miquel R, Solá A, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007;7:2180-2189.
29. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007;7:2788-2796.
30. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996;128:251-258.
31. Hardy KJ, McClure DN, Subwongcharoen S. Ischaemic preconditioning of the liver: a preliminary study. Aust N Z J Surg 1996;66:707-710.
32. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002;161:587-601.
33. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001;7:292-299.
34. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004;20:2580-2584.
35. Glanemann M, Langrehr JM, Stange BJ, Neumann U, Settmacher U, Steinmüller T, Neuhaus P. Clinical implidstions of hepatic preservation injury after adult liver transplantation. Am J Transplant 2003;3:1003-1009.
36. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
37. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007;7:990-997.
38. Selzner M, Selzner N, Jochum W, Graf R, Clavien PA. Increased ischemic injury in old mouse liver: an ATP-dependent mechanism. Liver Transpl 2007;13:382-390.
39. Schiesser M, Wittert A, Nieuwenhuijs VB, Morphett A, Padbury RT, Barritt GJ. Intermittent ischemia but not ischemic preconditioning is effective in restoring bile flow after ischemia reperfusion injury in the livers of aged rats. J Surg Res 2008.
40. Kloner RA, Przyklenk K, Shook T, Cannon CP. Protection conferred by preinfarct angina is manifest in the aged heart: evidence from the TIMI 4 trial. J Thromb Thrombolysis 1998;6:89-92.
41. Longobardi G, Abete P, Ferrara N, Papa A, Rosiello R, Furgi G, et al. "Warm-up" phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of "ischemic preconditioning" in the aging heart. J Gerontol A Biol Sci Med Sci 2000;55:M124-129.
42. Fenton RA, Dickson EW, Meyer TE, Dobson JG Jr. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol 2000;32:1371-1375.
43. Tomai F, Crea F, Ghini AS, Proietti I, Gaspardone A, Versaci F, et al. Ischemic preconditioning during coronary angioplasty is preserved in elderly patients. Ital Heart J 2000;1:562-568.
44. Przyklenk K, Li G, Whittaker P. No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits. J Am Coll Cardiol 2001;38:1741-1747.
45. Juhaszova M, Rabuel C, Zorov DB, Lakatta EG, Sollott SJ. Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res 2005;66:233-244.
46. He Z, Crook JE, Meschia JF, Brott TG, Dickson DW, McKinney M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr Neurovasc Res 2005;2:365-374.
47. Sniecinski R, Liu H. Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium. Anesthesiology 2004;100:589-597.
48. Riess ML, Camara AK, Rhodes SS, McCormick J, Jiang MT, Stowe DF. Increasing heart size and age attenuate anesthetic preconditioning in guinea pig isolated hearts. Anesth Analg 2005;101:1572-1576.
49. Honma Y, Tani M, Yamamura K, McCormick J, Jiang MT, Stowe DF. Preconditioning with heat shock further improved functional recovery in young adult but not in middle-aged rat hearts. Exp Gerontol 2003;38:299-306.
50. Abete P, Della Morte D, Mazzella F, D'Ambrosio D, Galizia G, Testa G, et al. Lifestyle and prevention of cardiovascular disease in the elderly: an Italian perspective. Am J Geriatr Cardiol 2006;15:28-34.
51. Boengler K, Konietzka I, Buechert A, Heinen Y, Garcia-Dorado D, Heusch G, Schulz R. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol 2007;292:H1764-1769.
52. Lee TM, Su SF, Chou TF, Lee YT, Tsai CH. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 2002;105:334-340.
53. Abete P, Ferrara N, Cacciatore F, Sagnelli E, Manzi M, Carnovale V, et al. High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients. J Am Coll Cardiol 2001;38:1357-1365.
54. Abete P, Testa G, Ferrara N, De Santis D, Capaccio P, Viati L, et al. Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. Am J Physiol Heart Circ Physiol 2002;282:H1978-1987.
55. Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C, et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 1996; 27:1777-17786.
56. Koneru B, Reddy MC, dela Torre AN, Patel D, Ippolito T, Ferrante RJ. Studies of hepatic warm ischemia in the obese Zucker rat. Transplantation 1995;59:942-946.
57. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-1251.
58. Lloris-Carsi J, Cejalvo D, Toledo-Pereyra L, Calvo M, Suzuki S. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993;25:3303-3304.
59. Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF, et al. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg 2005;101:1577-1583.
60. Compagnon P, Lindell S, Ametani MS, Gilligan B, Wang HB, D'Alessandro AM, et al. Ischemic preconditioning and liver tolerance to warm or cold ischemia: experimental studies in large animals. Transplantation 2005;79:1393-1400.
61. Adam R, Arnault I, Bao YM, Salvucci M, Sebagh M, Bismuth H. Effect of ischemic preconditioning on hepatic tolerance to cold ischemia in the rat. Transpl Int 1998; 11(suppl 1):S168-S170.
62. Golling M, Mehrabi A, Blum K, Jahnke C, Kellner H, Bud O, et al. Effects of hemodynamic instability on brain death-induced prepreservation liver damage. Transplantation 2003:75:1154-1159.
63. Onumata O, Takahashi T, Ogawa K, Sato K, Kakita A. Effects of hypotension on hepatic circulation and function: comparison of brain death and exsanguination models. Transplant Proc 2000;32:2293-2296.
64. van der Hoeven JA, Ploeg RJ, Postema F, Molema I, de Vos P, Girbes AR, et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. Transplantation 1999;68:1884-1890.
65. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003;75:2001-2007.
66. Colombo G, Gatti S, Turcatti F, Lonati C, Sordi A, Rossi G, et al. Alteration in the transcriptional profile of livers from brain-dead organ donors. Transplantation 2006; 82:69-79.
67. Chiari P, Piriou V, Hadour G, Rodriguez C, Loufouat J, Lehot JJ, et al. Preservation of ischemia and isoflurane-induced preconditioning after brain death in rabbit hearts. Am J Physiol Heart Circ Physiol 2002;283:H1769-H1774.
68. Kirsch M, Farhat F, Garnier JP, Loisance D. Acute brain death abolishes the cardioprotective effects of ischemic preconditioning in the rabbit. Transplantation 2000;69: 2013-2019.
69. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 2001;33:1897-1918.
70. Watt KD, Lyden ER, Gulizia JM, McCashland TM. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Liver Transpl 2006;12:134-139.
71. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
72. Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001;234:384-393; discussion 393-394.
73. Schulz R, Walz MK, Behrends M, Neumann T, Gerken G, Heusch G. Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 2001;280:H198-207.
74. Ricciardi R, Schaffer BK, Kim RD, Shah SA, Donohue SE, Wheeler SM, et al. Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. Transplantation 2001;72:406-412.
75. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpi E, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29:126-132.
76. Koti RS, Yang W, Glantzounis G, Quaglia A, Davidson BR, Seifalian AM. Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis. Clin Sci (Lond) 2005; 108:55-63.
77. Schultz R, Walz MK, Behrends M, Neumann T, Gerken G, Heusch G. Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 2001;280:H198-207.
78. Ricciardi R, Schaffer BK, Kim RD, Shah SA. Donohue SE, Wheeler SM, et al. Protective effects of ischemic preconditioning in the cold-preserved liver are tyrosine kinase dependent. Transplantation 2001;72:406-412.
79. Kadono J, Hamada N, Fukueda M, Ishizaki N, Kaieda M, Gejima K, et al. Advantage of ischemic preconditioning for hepatic resection in pigs. J Surg Res 2006;134:173-181.
80. Shimoda M, Iwasaki Y, Sawada T, Kubota K. Protective effect of ischemic preconditioning against liver injury after major hepatectomy using the intermittent Pringle maneuver in swine. Pathobiology 2007;74:42-49.
81. Kanoria S, Jalan R, Davies NA, Seifalian AM, Williams R, Davidson BR. Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemiare-perfusion injury. Br J Surg 2006;93:762-768.
82. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-2282.
83. Oreopoulos GD, Wu H, Szaszi K, Fan J, Marshall JC, Khadaroo RG, et al. Hypertonic preconditioning prevents hepatocellular injury following ischemia/reperfusion in mice: a role for interleukin 10. Hepatology 2004;40:211-220.
84. Ozguc H, Tokyay R, Kahveci N, Serdar Z, Gür ES. Hypertonic saline dextran alleviates hepatic injury in hypovolemic rats undergoing porta hepatis occlusion. Shock 2003; 19:383-387.
85. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007;117:2583-2591.